Giulia Ceccardi

Cremona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study.

Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study.

Journal: Frontiers in neurology
Published: May 28, 2026

Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study.

Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study.

Journal: Journal of neurology
Published: January 09, 2026

Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.

Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 08, 2025

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: October 24, 2024

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.

Journal: Toxins
Published: October 08, 2023

Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.

Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.

Journal: European journal of neurology
Published: August 22, 2023

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.

Journal: Neurology international
Published: January 11, 2023

An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor.

An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor.

Journal: European journal of neurology
Published: January 09, 2023

Photophobia and migraine outcome during treatment with galcanezumab.

Photophobia and migraine outcome during treatment with galcanezumab.

Journal: Frontiers in neurology
Published: November 02, 2022

Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.

Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.

Journal: European neurology
Published: August 26, 2022

Post COVID-19 vaccination headache: A clinical and epidemiological evaluation.

Post COVID-19 vaccination headache: A clinical and epidemiological evaluation.

Journal: Frontiers in pain research (Lausanne, Switzerland)
Published: July 14, 2022

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 14, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026